As of September 2017, there were 525 CROs in China, of which 248 were clinical service enterprises and 262 non-clinical service enterprises. Location is mainly in Beijing, Shanghai and Jiangsu. 2004-14 was the peak period of CRO development, mainly benefiting from new “drug clinical trial quality management practices involving GCP, GLP and other industry policies. A common feature is that CROs are usually located in industrial parks, and their talent and education resources are abundant.”
China Bio news release, October 30, 2017
China counts over 500 CRO organizations, half in biomedicine